Cabaletta Bio (CABA) Shareholder's Equity (QoQ) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Cabaletta Bio | 194.84 Mn | 61.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -19.66% |
| Sep 30, 2025 | -21.86% |
| Jun 30, 2025 | 46.83% |
| Mar 31, 2025 | -20.21% |
| Dec 31, 2024 | -12.57% |
| Sep 30, 2024 | -12.67% |
| Jun 30, 2024 | -10.01% |
| Mar 31, 2024 | -6.13% |
| Dec 31, 2023 | 46.78% |
| Sep 30, 2023 | -7.59% |
| Jun 30, 2023 | 90.00% |
| Mar 31, 2023 | -12.31% |
| Dec 31, 2022 | 21.71% |
| Sep 30, 2022 | -10.11% |
| Jun 30, 2022 | -10.49% |
| Mar 31, 2022 | -9.53% |
| Dec 31, 2021 | 1.15% |
| Sep 30, 2021 | 15.09% |
| Jun 30, 2021 | -1.92% |
| Mar 31, 2021 | -5.69% |
| Dec 31, 2020 | -6.78% |
| Sep 30, 2020 | -5.72% |
| Jun 30, 2020 | -5.37% |
| Mar 31, 2020 | -4.78% |
| Dec 31, 2019 | 630.47% |
| Sep 30, 2019 | -18.56% |
| Jun 30, 2019 | -15.44% |
| Mar 31, 2019 | -78.22% |
| Dec 31, 2018 | -4.60% |